Cargando…

Can visuospatial measures improve the diagnosis of Alzheimer's disease?

INTRODUCTION: Overlapping and evolving symptoms lead to ambiguity in the diagnosis of dementia. Visuospatial function relies on parietal lobe function, which may be affected in the early stages of Alzheimer's disease (AD). This review evaluates visuospatial dysfunction in patients with AD, fron...

Descripción completa

Detalles Bibliográficos
Autores principales: Salimi, Shirin, Irish, Muireann, Foxe, David, Hodges, John R., Piguet, Olivier, Burrell, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956809/
https://www.ncbi.nlm.nih.gov/pubmed/29780858
http://dx.doi.org/10.1016/j.dadm.2017.10.004
_version_ 1783323954900893696
author Salimi, Shirin
Irish, Muireann
Foxe, David
Hodges, John R.
Piguet, Olivier
Burrell, James R.
author_facet Salimi, Shirin
Irish, Muireann
Foxe, David
Hodges, John R.
Piguet, Olivier
Burrell, James R.
author_sort Salimi, Shirin
collection PubMed
description INTRODUCTION: Overlapping and evolving symptoms lead to ambiguity in the diagnosis of dementia. Visuospatial function relies on parietal lobe function, which may be affected in the early stages of Alzheimer's disease (AD). This review evaluates visuospatial dysfunction in patients with AD, frontotemporal dementia, dementia with Lewy bodies, and vascular dementia to determine the diagnostic and prognostic potential of visuospatial tasks in AD. METHODS: A systematic search of studies (1960–2016) investigating visuospatial dysfunction in dementia was conducted. RESULTS: Tests measuring construction, specifically Block Design and Clock Drawing Test, and visual memory, specifically Rey-Osterrieth Complex Figure recall and topographical tasks, show the greatest diagnostic potential in dementia. The Benton visual retention, Doors and People, and topographical memory tests show potential as prognostic markers. DISCUSSION: Tests of visuospatial function demonstrate significant diagnostic and prognostic potential in dementia. Further studies with larger samples of pathologically confirmed cases are required to verify clinical utility.
format Online
Article
Text
id pubmed-5956809
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59568092018-05-18 Can visuospatial measures improve the diagnosis of Alzheimer's disease? Salimi, Shirin Irish, Muireann Foxe, David Hodges, John R. Piguet, Olivier Burrell, James R. Alzheimers Dement (Amst) Cognitive & Behavioral Assessment INTRODUCTION: Overlapping and evolving symptoms lead to ambiguity in the diagnosis of dementia. Visuospatial function relies on parietal lobe function, which may be affected in the early stages of Alzheimer's disease (AD). This review evaluates visuospatial dysfunction in patients with AD, frontotemporal dementia, dementia with Lewy bodies, and vascular dementia to determine the diagnostic and prognostic potential of visuospatial tasks in AD. METHODS: A systematic search of studies (1960–2016) investigating visuospatial dysfunction in dementia was conducted. RESULTS: Tests measuring construction, specifically Block Design and Clock Drawing Test, and visual memory, specifically Rey-Osterrieth Complex Figure recall and topographical tasks, show the greatest diagnostic potential in dementia. The Benton visual retention, Doors and People, and topographical memory tests show potential as prognostic markers. DISCUSSION: Tests of visuospatial function demonstrate significant diagnostic and prognostic potential in dementia. Further studies with larger samples of pathologically confirmed cases are required to verify clinical utility. Elsevier 2017-11-06 /pmc/articles/PMC5956809/ /pubmed/29780858 http://dx.doi.org/10.1016/j.dadm.2017.10.004 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Cognitive & Behavioral Assessment
Salimi, Shirin
Irish, Muireann
Foxe, David
Hodges, John R.
Piguet, Olivier
Burrell, James R.
Can visuospatial measures improve the diagnosis of Alzheimer's disease?
title Can visuospatial measures improve the diagnosis of Alzheimer's disease?
title_full Can visuospatial measures improve the diagnosis of Alzheimer's disease?
title_fullStr Can visuospatial measures improve the diagnosis of Alzheimer's disease?
title_full_unstemmed Can visuospatial measures improve the diagnosis of Alzheimer's disease?
title_short Can visuospatial measures improve the diagnosis of Alzheimer's disease?
title_sort can visuospatial measures improve the diagnosis of alzheimer's disease?
topic Cognitive & Behavioral Assessment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956809/
https://www.ncbi.nlm.nih.gov/pubmed/29780858
http://dx.doi.org/10.1016/j.dadm.2017.10.004
work_keys_str_mv AT salimishirin canvisuospatialmeasuresimprovethediagnosisofalzheimersdisease
AT irishmuireann canvisuospatialmeasuresimprovethediagnosisofalzheimersdisease
AT foxedavid canvisuospatialmeasuresimprovethediagnosisofalzheimersdisease
AT hodgesjohnr canvisuospatialmeasuresimprovethediagnosisofalzheimersdisease
AT piguetolivier canvisuospatialmeasuresimprovethediagnosisofalzheimersdisease
AT burrelljamesr canvisuospatialmeasuresimprovethediagnosisofalzheimersdisease